Phaarmasia Limited (PHRMASI.BO)
INR 51.87
(11.52%)
INR 51.87
(11.52%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 305.93 Million INR | 11.29% |
| 2022 | 274.89 Million INR | 59.68% |
| 2021 | 172.15 Million INR | -13.47% |
| 2020 | 198.95 Million INR | -18.64% |
| 2019 | 244.53 Million INR | -4.68% |
| 2018 | 256.54 Million INR | 27.14% |
| 2017 | 201.78 Million INR | 40.53% |
| 2016 | 143.59 Million INR | 9.15% |
| 2015 | 131.55 Million INR | 6.93% |
| 2014 | 123.02 Million INR | -18.84% |
| 2013 | 151.59 Million INR | 118.49% |
| 2012 | 69.38 Million INR | -79.78% |
| 2011 | 343.19 Million INR | -24.37% |
| 2010 | 453.79 Million INR | 375.73% |
| 2009 | 95.38 Million INR | -11.48% |
| 2008 | 107.76 Million INR | -1.9% |
| 2007 | 109.85 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 82.91 Million INR | -16.99% |
| 2023 Q4 | 99.89 Million INR | 96.48% |
| 2023 Q3 | 50.84 Million INR | -41.19% |
| 2023 FY | 305.93 Million INR | 11.29% |
| 2023 Q1 | 68.75 Million INR | -8.36% |
| 2023 Q2 | 86.44 Million INR | 25.73% |
| 2022 Q1 | 53.79 Million INR | 29.2% |
| 2022 FY | 274.89 Million INR | 59.68% |
| 2022 Q4 | 75.02 Million INR | -5.54% |
| 2022 Q3 | 79.42 Million INR | 19.16% |
| 2022 Q2 | 66.65 Million INR | 23.91% |
| 2021 Q3 | 38.72 Million INR | -26.79% |
| 2021 FY | 172.15 Million INR | -13.47% |
| 2021 Q1 | 38.89 Million INR | -27.49% |
| 2021 Q4 | 41.63 Million INR | 7.51% |
| 2021 Q2 | 52.9 Million INR | 36.0% |
| 2020 Q4 | 53.64 Million INR | 11.37% |
| 2020 Q3 | 48.16 Million INR | 7.91% |
| 2020 Q1 | 52.51 Million INR | -4.27% |
| 2020 Q2 | 44.63 Million INR | -15.0% |
| 2020 FY | 198.95 Million INR | -18.64% |
| 2019 FY | 244.53 Million INR | -4.68% |
| 2019 Q1 | 82.52 Million INR | -34.76% |
| 2019 Q2 | 39.42 Million INR | -52.22% |
| 2019 Q3 | 67.72 Million INR | 71.77% |
| 2019 Q4 | 54.85 Million INR | -19.0% |
| 2018 Q2 | 38.37 Million INR | -7.53% |
| 2018 FY | 256.54 Million INR | 27.14% |
| 2018 Q4 | 126.49 Million INR | 152.11% |
| 2018 Q3 | 50.17 Million INR | 30.73% |
| 2018 Q1 | 41.5 Million INR | -19.66% |
| 2017 Q2 | 35.29 Million INR | -35.59% |
| 2017 Q3 | 72.31 Million INR | 104.89% |
| 2017 Q4 | 51.65 Million INR | -28.57% |
| 2017 Q1 | 54.8 Million INR | -8.25% |
| 2017 FY | 201.78 Million INR | 40.53% |
| 2016 FY | 143.59 Million INR | 9.15% |
| 2016 Q3 | 57 Million INR | 97.37% |
| 2016 Q2 | 28.88 Million INR | -28.57% |
| 2016 Q4 | 59.73 Million INR | 4.78% |
| 2016 Q1 | 40.43 Million INR | 15.18% |
| 2015 Q2 | 43.48 Million INR | 103.82% |
| 2015 Q3 | 31.62 Million INR | -27.28% |
| 2015 Q4 | 35.1 Million INR | 11.03% |
| 2015 Q1 | 21.33 Million INR | -39.48% |
| 2015 FY | 131.55 Million INR | 6.93% |
| 2014 Q1 | 29.38 Million INR | -3.71% |
| 2014 Q4 | 35.25 Million INR | 16.69% |
| 2014 Q3 | 30.21 Million INR | 7.25% |
| 2014 Q2 | 28.17 Million INR | -4.14% |
| 2014 FY | 123.02 Million INR | -18.84% |
| 2013 Q3 | 23.59 Million INR | -51.58% |
| 2013 Q1 | 48.76 Million INR | 94.38% |
| 2013 FY | 151.59 Million INR | 118.49% |
| 2013 Q2 | 48.72 Million INR | -0.09% |
| 2013 Q4 | 30.52 Million INR | 29.37% |
| 2012 Q2 | 10.23 Million INR | -39.61% |
| 2012 Q4 | 25.08 Million INR | 43.12% |
| 2012 Q3 | 17.52 Million INR | 71.28% |
| 2012 Q1 | 16.94 Million INR | -46.29% |
| 2012 FY | 69.38 Million INR | -79.78% |
| 2011 Q4 | 31.55 Million INR | -17.42% |
| 2011 Q2 | 96.39 Million INR | 0.0% |
| 2011 Q3 | 38.21 Million INR | -60.36% |
| 2011 FY | 343.19 Million INR | -24.37% |
| 2010 FY | 453.79 Million INR | 375.73% |
| 2009 FY | 95.38 Million INR | -11.48% |
| 2008 Q4 | 16.75 Million INR | 0.0% |
| 2008 FY | 107.76 Million INR | -1.9% |
| 2007 FY | 109.85 Million INR | 0.0% |
| 2007 Q4 | 47.57 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -2816.554% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 70.829% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 23.561% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 17.357% |
| Sunil Healthcare Limited | 901.91 Million INR | 66.08% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -1564.307% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.456% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 31.419% |
| Patidar Buildcon Limited | 2.3 Million INR | -13155.329% |
| Roopa Industries Limited | 715.53 Million INR | 57.244% |
| Smruthi Organics Limited | 1.27 Billion INR | 76.032% |
| Trident Lifeline Limited | 446.28 Million INR | 31.449% |
| PANJON LTD. | 125.52 Million INR | -143.731% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -102.442% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 36.23% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 95.272% |
| Crestchem Limited | 212.56 Million INR | -43.926% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -5410.321% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 54.529% |
| Tyche Industries Limited | 696.83 Million INR | 56.097% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 91.213% |
| Trimurthi Limited | 42.23 Million INR | -624.307% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 58.975% |
| Norris Medicines Limited | 56.35 Million INR | -442.857% |
| Zenlabs Ethica Limited | 585.63 Million INR | 47.76% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 75.606% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 79.061% |
| Parmax Pharma Limited | 154.24 Million INR | -98.344% |
| Veerhealth Care Limited | 142.13 Million INR | -115.243% |
| Deccan Health Care Limited | 597.28 Million INR | 48.78% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 93.4% |
| Makers Laboratories Limited | 1.03 Billion INR | 70.516% |
| Lactose (India) Limited | 1.13 Billion INR | 73.138% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 22.826% |
| Zenith Healthcare Limited | 144.71 Million INR | -111.401% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 43.016% |
| Bacil Pharma Limited | - INR | -Infinity% |
| PRAVEG LIMITED | 915.96 Million INR | 66.6% |
| Denis Chem Lab Limited | 1.67 Billion INR | 81.77% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 90.04% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 78.45% |
| Colinz Laboratories Limited | 70.29 Million INR | -335.207% |
| Godavari Drugs Limited | 1.56 Billion INR | 80.478% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -27264.311% |
| Zenotech Laboratories Limited | 368.08 Million INR | 16.886% |
| Panchsheel Organics Limited | 1.05 Billion INR | 70.924% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 75.699% |
| Vivanza Biosciences Limited | 278.89 Million INR | -9.696% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 97.744% |
| Medi-Caps Limited | 265.63 Million INR | -15.17% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 15.664% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 81.985% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 82.451% |
| Mercury Laboratories Limited | 755.59 Million INR | 59.511% |
| Gennex Laboratories Limited | 867.14 Million INR | 64.719% |
| BDH Industries Limited | 858.31 Million INR | 64.356% |
| Coral Laboratories Limited | 836.6 Million INR | 63.432% |
| Concord Drugs Limited | 449.24 Million INR | 31.901% |
| Bharat Parenterals Limited | 2.59 Billion INR | 88.207% |
| Beryl Drugs Limited | 271.24 Million INR | -12.788% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -197.375% |
| Evoq Remedies Limited | 63.09 Million INR | -384.915% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 84.861% |
| Transchem Limited | 4.09 Million INR | -7361.782% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -101.436% |
| Parnax Lab Limited | 1.88 Billion INR | 83.788% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -12.077% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 70.105% |
| Cian Healthcare Limited | 616.95 Million INR | 50.412% |
| Trinity League India Limited | 2.95 Million INR | -10270.61% |
| Syschem (India) Limited | 2.33 Billion INR | 86.9% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 80.316% |
| Auro Laboratories Limited | 526.99 Million INR | 41.948% |